.png)
On November 3, 2026, Massachusetts voters will decide the future of legal cannabis in the Commonwealth. Question 8 asks whether to repeal the adult-use laws voters themselves approved a decade ago.
We're a small Massachusetts cannabis company with stores in Norton, Fairhaven and New Bedford. Our team, our neighbors and our customers all have something on the line here. So we're going to be direct with you: vote No on Question 8.
Question 8, formally titled "An Act to Restore a Sensible Marijuana Policy," would repeal the state laws that legalize, regulate and tax adult-use cannabis sales in Massachusetts. It would also eliminate the ability of adults to grow cannabis at home for personal use.
Under the proposal, limited personal possession by adults 21 and older would remain legal, and the medical marijuana program would stay in place. What disappears is the regulated retail system — the licensed, tested, tracked, taxed part.
A YES vote means repealing legal adult-use sales.A NO vote means keeping the current system in place. No change.
If that sounds backwards, you're reading it right. On this question, "No" is the vote that protects legalization.
The thing that gets lost in ballot-question shorthand is what the regulated market actually provides.
Tested products. Every product on a Massachusetts dispensary shelf is analyzed by an independent, licensed laboratory before it can be sold. Cannabinoid content is verified. Contaminants are screened for. You can scan a QR code and read the lab report for your specific batch. None of that exists outside the regulated system.
Age verification. Licensed dispensaries check ID at the door, every time, no exceptions. Unregulated sellers do not.
Local jobs and local businesses. The Stop the Repeal campaign points to more than 700 licensed cannabis businesses in the Commonwealth and thousands of Massachusetts jobs tied to them. These are budtenders, cultivators, drivers, packagers, security staff, accountants and compliance managers — people with mortgages and kids in local schools.
Public revenue. Since legalization, the industry has generated roughly $2 billion in state and local revenue, money that flows to municipal host communities, public health programs, public safety and the General Fund. Repeal doesn't reduce cannabis use. It just stops collecting on it.
Consumer protection generally. Labeled products. Child-resistant packaging. Traceability from cultivation to sale. Recourse if something's wrong. An illicit market offers none of it.
This isn't a grassroots Massachusetts effort. The signature drive that put Question 8 on the ballot was funded almost entirely by SAM Action Inc., an out-of-state prohibitionist organization, which put more than $1.5 million into the campaign.
Reporting has also documented complaints from Massachusetts residents who signed the petition and later said they were not told what they were signing. Two separate challenges to those signatures were filed and rejected, and the question is now on the ballot.
Massachusetts voters approved adult-use cannabis by a 54-46 margin in 2016. Question 8 asks the state to undo that decision — and the money to get it there came from outside the state.
Polling has consistently shown Massachusetts voters oppose repeal. A statewide survey conducted August 5–12, 2026 by UMass Amherst and WCVB found about 55% of registered voters planned to vote No, with 33% planning to vote Yes and roughly 10% undecided.
That's a comfortable margin — right up until you remember that polls don't cast ballots. In a nine-question election with a long, multi-page ballot, the outcome comes down to who actually shows up and who makes it all the way to Question 8.
Mark these dates:
Massachusetts offers no-excuse voting by mail and in-person early voting, so you have options well before Election Day. You can check your registration status and find your polling location through the Secretary of the Commonwealth's office at sec.state.ma.us.
The single most useful thing you can do right now takes less than a minute: pledge to vote No on Question 8.
Pledges matter more than they sound like they should. Voters who commit in advance are significantly more likely to actually turn out, and the campaign uses pledge counts to know where to focus outreach in the final weeks. It's a name, an email, thirty seconds.
The repeal effort arrived with more than $1.5 million from a single out-of-state organization. The opposition is funded by Massachusetts businesses, workers and residents — people who live here.
If you're able, donate to the Committee to Protect Cannabis Regulation, the official ballot committee opposing Question 8. It's the entity running the Stop the Repeal campaign, and contributions fund voter education, advertising and get-out-the-vote work between now and November 3.
Small amounts add up. Ten dollars from a lot of people beats a million from one organization that couldn't find Fairhaven on a map.
Check your registration. Especially if you've moved recently. It takes about a minute.
Make a plan to vote. Early, by mail, or on November 3 — just decide which one and put it on your calendar.
Find Question 8 on your ballot. It's the eighth of nine questions this year, on a ballot that will run two or three pages in most towns. Don't stop before you get there.
Tell five people. Most voters haven't heard about this yet. You don't have to consume cannabis to care about voter-approved laws being overturned with out-of-state money, or about thousands of Massachusetts jobs.
Learn more. The Stop the Repeal campaign has additional resources at stoptherepealma.com.
We've spent years building something here — a licensed business, a trained team, relationships with growers across the state and a place on the South Coast where adults can buy tested products from people who know what they're selling.
We'd like to keep doing that. On November 3, vote No on Question 8.
Take the pledge · Donate to the campaign · stoptherepealma.com
Visit CANA:
Please consume responsibly. For use only by adults 21 years of age or older. Keep out of the reach of children. This product has not been analyzed or approved by the Food and Drug Administration (FDA). There is limited information on the side effects of using this product, and there may be associated health risks.
